9th IOF Asia-Pacific Bone Health Conference set to open in Tokyo
Meeting Announcement
Updates every hour. Last Updated: 31-Dec-2025 17:11 ET (31-Dec-2025 22:11 GMT/UTC)
Hereditary hemorrhagic telangiectasia (HHT) is the second most common inherited bleeding disorder worldwide, affecting 1 in 3,800 persons. HHT’s hallmark symptom is chronic nosebleeds, which often occur alongside other internal bleeding and vascular malformations that impact quality of life and longevity. A new study from Mass General Brigham tested the safety and efficacy of engasertib, a drug specifically designed to target the condition. This 75-participant, double-blind, placebo-controlled trial found engasertib was safe and decreased nosebleed frequency and duration. Their results are published in New England Journal of Medicine.
Soybean oil, the most widely consumed cooking oil in the United States and a staple of processed foods, contributes to obesity, at least in mice, through a mechanism scientists are now beginning to understand.
UBC researchers built a ‘body-swap’ robot to uncover how the brain maintains balance—a breakthrough that could lead to new fall-prevention strategies and assistive technologies for older adults.
Researchers have decoded the signalling pathway that inhibits nerve regeneration in diabetes and have developed a therapeutic peptide that could transform the treatment—and possibly even the prevention—of diabetic nerve damage, published in Science Translational Medicine.